Design Therapeutics Inc.

Last updated September 27, 2026

Organization details

Legal name
Design Therapeutics Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
Carlsbad
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
DSGN
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001807120
EIN
82-3929248

Board of directors

Chief executives

Joao Siffert M.D. · President and CEO
Dates unknown
Pratik Shah · President, CEO and Chairperson
Dates unknown

Director election results

Annual meeting of June 9, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

5 of this board's directors also sit on 13 other boards. 12 are in the same sector.

Network of Design Therapeutics Inc.'s board connections ADARx Pharmaceuticals Inc. ADARx Pharmaceuticals... ARS Pharmaceuticals Inc. ARS Pharmaceuticals In... AnaptysBio Inc. AnaptysBio Inc. BlossomHill Therapeutics Inc. BlossomHill Therapeuti... BridgeBio Oncology Therapeutics Inc. BridgeBio Oncology The... COMPASS Pathways Plc COMPASS Pathways Plc CRISPR Therapeutics AG CRISPR Therapeutics AG Damora Therapeutics Inc. Damora Therapeutics In... First Tracks Biotherapeutics Inc. First Tracks Biotherap... Helix Acquisition Corp. III Helix Acquisition Corp... Nkarta Inc. Nkarta Inc. Xenon Pharmaceuticals Inc. Xenon Pharmaceuticals... Xeris Biopharma Holdings Inc. Xeris Biopharma Holdin... David Shapiro David Shapiro John P. Schmid John P. Schmid Justin D. Gover Justin D. Gover Pratik Shah Pratik Shah Simeon George Simeon George Design Therapeutics Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Aug 13, 2025 Arsani William Director Open-market sale −345,000 $5.25 $1,811,250
Aug 13, 2025 Arsani William Director Open-market sale −217,627 $5.25 $1,142,542
Dec 18, 2024 Deepa Prasad Director Open-market sale −3,806 $6.27 $23,864
Aug 9, 2024 Arsani William Director Open-market sale −814,874 $4.25 $3,463,215
Mar 25, 2024 Heather A. Berger Director Open-market purchase +1,300 $3.74 $4,862
Mar 25, 2024 John P. Schmid Director Open-market purchase +17,809 $3.74 $66,606
Mar 22, 2024 John P. Schmid Director Open-market purchase +9,156 $3.62 $33,145
Sep 29, 2023 Rodney W. Lappe Director Open-market purchase +21,000 $2.35 $49,350
Aug 29, 2023 Deepa Prasad Director Open-market purchase +12,000 $2.31 $27,720
Aug 29, 2023 Arsani William Director Open-market purchase +1,960,000 $2.44 $4,782,400
Aug 28, 2023 Arsani William Director Open-market purchase +275,000 $2.15 $591,250

Organizations in the same sector, closest in location and size first.

Questions about Design Therapeutics Inc.

Who is the CEO of Design Therapeutics Inc.?

Joao Siffert M.D. is Design Therapeutics Inc.'s President and CEO.

How many directors are on Design Therapeutics Inc.'s board?

Design Therapeutics Inc.'s board has 11 directors: Arsani William, David Shapiro, Deepa Prasad, Heather A. Berger, Joao Siffert M.D., John P. Schmid, Justin D. Gover, Pratik Shah, Rodney W. Lappe, Simeon George and 1 other.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="design-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.